Holen Sie sich die Stockscreener-App
15.89
0.69%
-0.11
Handel nachbörslich:
15.91
0.02
+0.13%
Schlusskurs vom Vortag:
$16.00
Offen:
$15.62
24-Stunden-Volumen:
170.87K
Relative Volume:
0.23
Marktkapitalisierung:
$493.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-49.81M
KGV:
-7.3701
EPS:
-2.156
Netto-Cashflow:
$-42.93M
1W Leistung:
-10.73%
1M Leistung:
+14.81%
6M Leistung:
+535.60%
1J Leistung:
+260.32%
1-Tages-Spanne:
$15.48
$16.02
1-Wochen-Bereich:
$14.08
$17.95
52-Wochen-Spanne:
$1.60
$20.91
Alto Neuroscience Inc Stock (ANRO) Company Profile
Firmenname
Alto Neuroscience Inc
Sektor
Branche
Telefon
773-255-5012
Adresse
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW
Vergleichen Sie ANRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANRO
Alto Neuroscience Inc
|
15.89 | 497.06M | 0 | -49.81M | -42.93M | -2.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alto Neuroscience Inc Stock (ANRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Fortgesetzt | Chardan Capital Markets | Buy |
| 2025-11-17 | Eingeleitet | BTIG Research | Buy |
| 2025-09-29 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-10-23 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
| 2024-10-23 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-09-03 | Eingeleitet | Wedbush | Outperform |
| 2024-02-27 | Eingeleitet | Jefferies | Buy |
| 2024-02-27 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-02-27 | Eingeleitet | Stifel | Buy |
| 2024-02-27 | Eingeleitet | TD Cowen | Outperform |
| 2024-02-27 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Alto Neuroscience Inc Aktie (ANRO) Neueste Nachrichten
Is Alto Neuroscience Inc. stock bottoming after sell offWeekly Market Report & Consistent Income Trade Ideas - ulpravda.ru
Why Alto Neuroscience Inc. stock could be next big winnerMarket Sentiment Report & Long-Term Growth Portfolio Plans - ulpravda.ru
Is Alto Neuroscience Inc. stock a good choice for value investorsPortfolio Diversification Tips & Low Cost Capital Gains - ulpravda.ru
Is Alto Neuroscience Inc. stock supported by strong fundamentals2026 world cup usa national team qualification young talents high defensive line group prediction guide - ulpravda.ru
Chardan Capital Markets assumes coverage on Alto Neuroscience stock with Buy rating - Investing.com Canada
Chardan Capital Doubles Price Target for ANRO to $30 and Maintai - GuruFocus
Chardan Capital Raises Alto Neuroscience (NYSE:ANRO) Price Target to $30.00 - MarketBeat
Alto Neuroscience (NYSE:ANRO) Shares Down 6%What's Next? - MarketBeat
Does Alto Neuroscience Inc. stock trade at a discount to peersHead and Shoulders Patterns & Superior Portfolio Growth - bollywoodhelpline.com
Alto Neuroscience, Inc.'s (NYSE:ANRO) Institutional Investors Lost 10% Over the Past Week but Have Profited From Longer-term Gains - 富途牛牛
Alto Neuroscience (NYSE:ANRO) Stock Price Down 5.6%Here's Why - MarketBeat
Alto Neuroscience, Inc. (NYSE:ANRO) is definitely on the radar of institutional investors who own 33% of the company - Yahoo Finance
Alto Neuroscience Stock 9-Day Winning Spree: Stock Climbs 51% - Trefis
Will Alto Neuroscience Inc. stock continue upward momentumJuly 2025 Outlook & Fast Moving Stock Trade Plans - Улправда
Alto Neuroscience, Inc. (NYSE:ANRO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Volume Summary: What sentiment indicators say about Alto Neuroscience Inc stockJuly 2025 Update & Accurate Trade Setup Notifications - moha.gov.vn
Is Alto Neuroscience Inc. stock safe for conservative investors2025 Institutional Moves & AI Forecast for Swing Trade Picks - Улправда
Market Review: Does Alto Neuroscience Inc. stock trade at a discount to peersJuly 2025 Momentum & Low Drawdown Investment Ideas - Улправда
Alto Neuroscience Stock Rockets 51% With 8-Day Winning Streak - Trefis
What margin trends mean for Alto Neuroscience Inc. stock2025 Price Action Summary & Safe Capital Investment Plans - Улправда
How Alto Neuroscience Inc. stock benefits from global expansion2025 Biggest Moves & Verified Momentum Stock Watchlist - DonanımHaber
Will Alto Neuroscience Inc. stock sustain uptrend momentum2025 Winners & Losers & Daily Stock Trend Watchlist - DonanımHaber
Stock Analysis: Is Alto Neuroscience Inc. stock a good choice for value investors2025 Price Targets & Daily Volume Surge Trade Alerts - Улправда
Why Alto Neuroscience Inc. stock remains undervaluedJuly 2025 Volume & Consistent Profit Alerts - Улправда
Faruqi & Faruqi Reminds Alto Neuroscience Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 19, 2025ANRO - TMX Newsfile
Alto Neuroscience (NYSE:ANRO) Stock Price Up 7.1%Here's Why - MarketBeat
Alto Neuroscience (NYSE:ANRO) Shares Gap DownWhat's Next? - MarketBeat
Alto Neuroscience (NYSE:ANRO) Sets New 12-Month HighShould You Buy? - MarketBeat
Alto Neuroscience, Inc. $ANRO Shares Sold by AWM Investment Company Inc. - MarketBeat
Alto Neuroscience Is Down Nearly 35% This Year, But Retail Traders Keep Flocking To Micro-Cap Stock - MSN
Market Trends: Is Alto Neuroscience Inc stock recession proofDay Trade & Verified Swing Trading Watchlist - moha.gov.vn
ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Can Alto Neuroscience Inc. stock maintain growth trajectoryWeekly Loss Report & Technical Analysis for Trade Confirmation - Newser
Will Alto Neuroscience Inc. stock announce special dividendWeekly Trade Summary & Verified Momentum Watchlists - Newser
Aug Wrap: Is Alto Neuroscience Inc. stock supported by strong fundamentalsJuly 2025 News Drivers & Precise Swing Trade Alerts - BỘ NỘI VỤ
What insider purchases suggest about Alto Neuroscience Inc. stockQuarterly Portfolio Report & AI Enhanced Trade Execution Alerts - Newser
Alto Neuroscience Announces New Employee Inducement Grants Under NYSE Rule 303A.08December 3, 2025 - BioSpace
Is Alto Neuroscience Inc. stock undervalued after correctionTrade Volume Summary & Long-Term Growth Plans - Newser
Can Alto Neuroscience Inc. stock double in next 5 yearsMarket Activity Report & Safe Investment Capital Preservation Plans - Newser
What technical patterns form on Alto Neuroscience Inc. stock chartsPortfolio Performance Summary & Step-by-Step Swing Trade Plans - Newser
Is Alto Neuroscience Inc. stock safe for risk averse investorsQuarterly Profit Report & AI Driven Price Forecasts - Newser
What dividend safety rating applies to Alto Neuroscience Inc. stockJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - Newser
What sentiment indicators say about Alto Neuroscience Inc. stock - Newser
Alto Neuroscience (ANRO) Stock Analysis Report | Financials & Insights - Benzinga
Short Covering: Why Alto Neuroscience Inc. stock remains undervaluedJuly 2025 Action & Advanced Technical Signal Analysis - moha.gov.vn
Finanzdaten der Alto Neuroscience Inc-Aktie (ANRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):